AMYNDAS PHARMACEUTICALS S.A.
Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the complement system.
AMYNDAS PHARMACEUTICALS S.A.
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.amyndas.com
Status:
Active
Contact:
+1 (484) 620-3236
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
addmedica
ADDMEDICA is a medical product company.
Akela Pharma
Akela Pharma is a Pharmaceutical company.
AR Pharma
A pharmaceutical company.
Arkopharma
Arkopharma is a pharmaceutical company.
Aurobindo Pharma USA, Inc.
Aurobindo Pharma is a pharmaceuticals company offering generic pharmaceuticals.
Biomedicina
Biomedicina is a pharmaceutical company.
CBM Biopharma
CBM Biopharma is a pharmaceutical company.
Enject
Enject is a pharmaceutical preparation manufacturing.
Facio Therapies
Facio Therapies is a single-minded pharmaceutical company.
Galaxy Biotech
Galaxy Biotech is a pharmaceutical company.
Maas BiolAB
Maas Biolab is a small neuropharmaceutical company
Neuraxpharm
Neuraxpharm is a Pharmaceutical Company.
SERB
Brussels-based specialty pharma company.
Current Employees Featured
Founder
Official Site Inspections
http://www.amyndas.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.33 K
- Host name: 169.142.69.34.bc.googleusercontent.com
- IP address: 34.69.142.169
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amyndas Pharmaceuticals S.A." on Search Engine
Home – Amyndas Pharmaceuticals
Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the complement system.See details»
What We Do – Amyndas Pharmaceuticals
Amyndas is a fast-developing innovator and emerging leader in the field of “complement therapeutics,” with a compelling investment proposition, a highly promising pipeline and …See details»
Management – Amyndas Pharmaceuticals
Management. Despina Yancopoulou, PhD, MBA, Managing Director, member of the Amyndas BoD. Strong science and business background. Extensive R&D management …See details»
The Aplastic Anemia & MDS International Foundation supports …
Sep 21, 2015 11:46am. Amyndas Pharmaceuticals S.A. is pleased to announce today that the Aplastic Anemia & MDS International Foundation (AA&MDSIF) is endorsing the …See details»
Amyndas Announces Positive Top-Line Phase 2 Results for …
Mar 19, 2021 ATHENS, Greece-- ( BUSINESS WIRE )-- Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of novel …See details»
Amyndas Pharmaceuticals S.A. - Crunchbase
Details. Industries. Biotechnology. Pharmaceutical. Headquarters Regions Greater Philadelphia Area, Great Lakes, Northeastern US. Founders John Lambris. Operating …See details»
Amyndas’ lead candidate AMY-101 receives orphan drug
Feb 29, 2016 Amyndas Pharmaceuticals SA, which is committed to developing innovative therapeutics to treat complement-mediated disorders, announced today that …See details»
FDA grants orphan drug designation for PNH to Amyndas …
Oct 12, 2014 Amyndas Pharmaceuticals SA, the complement therapeutics company, announced that the U.S. Food and Drug Administration (FDA) has granted AMY-101, a …See details»
Amyndas Pharmaceuticals | VentureRadar
Location: USA. Founded in 2013. Private Company. Develops innovative peptide-based therapies targeting a range of disorders, including neurological, metabolic, and immune …See details»
Amyndas : Announces Positive Top-Line Phase 2 Results for ...
Mar 19, 2021 About Amyndas Pharmaceuticals. Amyndas Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing the most advanced …See details»
Amyndas Pharmaceuticals S.A. | Institution outputs - Nature
Home. Institution outputs. Amyndas Pharmaceuticals S.A. Greece. Research. Collaboration. Relationships. Research. Date range: 1 June 2022 - 31 May 2023. Region: …See details»
First Circuit Affirms Dismissal of Trade Secret Claims Under …
Sep 6, 2022 On September 2, the U.S. Court of Appeals for the First Circuit issued a decision in Amyndas Pharmaceuticals, S.A. v. Zealand Pharma AS affirming the …See details»
Our Focus – Amyndas Pharmaceuticals
Amyndas is developing novel therapeutics with enhanced properties to fight complement-mediated diseases that remain untreated and improve existing treatment modalities. …See details»
Organization | Amyndas Pharmaceuticals S.A. - CDEK
Amyndas Pharmaceuticals S.A. Report issue For profit Phase 2 Founded: Philadelphia PA United States (2014)See details»
Amyndas Pharmaceuticals LLC: Drug pipelines, Patents, Clinical …
Jun 1, 2023 Amyndas Pharmaceuticals LLC. Private Company|. Pennsylvania, United States. | www.amyndas.com. Private Company|. Pennsylvania, United States. | …See details»
Amyndas Pharmaceuticals S.A. - Contacts, Employees, Board …
Organization. Amyndas Pharmaceuticals S.A. Connect to CRM. Save. Summary People Technology Signals & News Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Amyndas Pharmaceuticals S.A. - Crunchbase
Companies like Amyndas Pharmaceuticals S.A. include Amplity, BRIM Biotechnology, and Nymox Pharmaceutical. Jenrin Discovery Philadelphia , Pennsylvania , United …See details»
Amyndas Pharmaceuticals - Philadelphia, Pennsylvania, United …
About. Amyndas is a fast-developing innovator and emerging leader in the field of “complement therapeutics”, with a compelling investment proposition, a highly promising …See details»
Our Pipeline – Amyndas Pharmaceuticals
Our Pipeline. Amyndas is developing the next generation Compstatins, compounds targeting complement inhibition on cell surfaces by Compsorbin, and compounds …See details»
Technology – Amyndas Pharmaceuticals
For relevant publications, click here. Read about Amyndas' technology, whose lead candidates are increasingly recognized by the scientific community as the best C3 based …See details»